ICATIBANT for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where ICATIBANT was used for Immunodeficiency common variable.
Most Reported Side Effects for ICATIBANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hereditary angioedema | 2,221 | 41.4% | 45 | 1,154 |
| Drug ineffective | 506 | 9.4% | 13 | 244 |
| Product dose omission issue | 421 | 7.9% | 8 | 238 |
| Weight decreased | 386 | 7.2% | 10 | 211 |
| Weight increased | 367 | 6.8% | 6 | 205 |
| Product use issue | 332 | 6.2% | 3 | 174 |
| Injection site pain | 331 | 6.2% | 2 | 106 |
| Inappropriate schedule of product administration | 305 | 5.7% | 5 | 165 |
| Headache | 294 | 5.5% | 3 | 128 |
| Malaise | 262 | 4.9% | 4 | 117 |
| Covid-19 | 260 | 4.9% | 11 | 142 |
| Stress | 234 | 4.4% | 1 | 108 |
| Off label use | 228 | 4.3% | 8 | 122 |
| Pain | 203 | 3.8% | 4 | 93 |
| Fall | 195 | 3.6% | 8 | 99 |
Other Indications for ICATIBANT
Hereditary angioedema (2,660)
Product used for unknown indication (930)
Immune system disorder (847)
Complement deficiency disease (338)
Complement factor abnormal (306)
Angioedema (153)
Hereditary angioedema with c1 esterase inhibitor deficiency (132)
Hereditary angioedema with normal c1 esterase inhibitor (63)
Prophylaxis (25)
Immunodeficiency (14)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)